Win-Partners Co

Win-Partners Co Equity Turnover

The Equity Turnover of Win-Partners Co (3183.T) as of Nov 4, 2026 is 3.88. In the previous year, Equity Turnover was 3.38 — a change of 14.75% (higher).

Equity Turnover

3.88

YoY

14.75%

Last updated:

Equity Turnover of Win-Partners Co is 2026 3.88 . Equity Turnover of Win-Partners Co was 2025 3.38 . It decreases by 14.75% higher compared to the previous year.

The Win-Partners Co Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2019
3.57 JPY
Jan 1, 2020
3.15 JPY
Jan 1, 2021
2.94 JPY
Jan 1, 2022
3.06 JPY
Jan 1, 2023
3.11 JPY
Jan 1, 2024
3.30 JPY
Jan 1, 2025
3.38 JPY
Jan 1, 2026
3.88 JPY
The Win-Partners Co Equity Turnover history
YEAREquity TurnoverYoY
3.88+14.75%
3.38+2.64%
3.30+5.96%
3.11+1.75%
3.06+4.00%
2.94-6.62%
3.15-11.83%
3.57+0.92%
3.54-5.12%
3.73-4.11%
3.89-3.74%
4.04-8.94%
4.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Win-Partners Co Stock analysis

What does Win-Partners Co do? WIN-Partners Co., Ltd. generates revenue through the management of its group of companies specializing in medical device sales. The company offers catheters for ischemic heart disease, pacemakers for cardiac rhythm management, artificial blood vessels for cardiovascular surgery, and embolization coils for peripheral vascular disease and brain surgery. Additionally, it provides large-scale medical equipment including computed tomography (CT) systems for radiology departments and operating rooms. Its primary customers are healthcare institutions requiring advanced medical technology solutions. The company's product portfolio targets specific medical specialties, with catheters, pacemakers, and artificial blood vessels serving cardiovascular applications. Embolization coils address vascular and neurological procedures, while CT equipment supports diagnostic imaging needs across various hospital departments. These offerings are distributed through the company's managed group of medical device sales entities. WIN-Partners focuses on high-value medical devices that require specialized sales channels and technical support. Its business model centers on managing a network of companies that handle the distribution and sales of these medical technologies to hospitals and clinics. The firm's revenue streams are derived from the sale of these specialized medical devices and equipment to healthcare providers in Japan and potentially international markets. Win-Partners Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Win-Partners Co stock

Equity Turnover of Win-Partners Co is 3.88 in 2026.

Equity Turnover of Win-Partners Co changed from 3.38 to 3.88, representing a 14.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Win-Partners Co since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Win-Partners Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Win-Partners Co

All Key Metrics — Win-Partners Co